Viatris Other Long-Term Assets 2010-2024 | VTRS

Viatris other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Viatris other long-term assets for the quarter ending September 30, 2024 were $2.466B, a 2.96% increase year-over-year.
  • Viatris other long-term assets for 2023 were $2.209B, a 8.1% decline from 2022.
  • Viatris other long-term assets for 2022 were $2.404B, a 105.3% increase from 2021.
  • Viatris other long-term assets for 2021 were $1.171B, a 11.76% increase from 2020.
Viatris Annual Other Long-Term Assets
(Millions of US $)
2023 $2,209
2022 $2,404
2021 $1,171
2020 $1,048
2019 $405
2018 $212
2017 $306
2016 $569
2015 $752
2014 $800
2013 $2,222
2012 $804
2011 $543
2010 $609
2009 $641
Viatris Quarterly Other Long-Term Assets
(Millions of US $)
2024-09-30 $2,466
2024-06-30 $2,445
2024-03-31 $2,232
2023-12-31 $2,209
2023-09-30 $2,395
2023-06-30 $2,351
2023-03-31 $2,418
2022-12-31 $2,404
2022-09-30 $964
2022-06-30 $997
2022-03-31 $1,056
2021-12-31 $1,171
2021-09-30 $1,040
2021-06-30 $1,025
2021-03-31 $1,020
2020-12-31 $1,048
2020-09-30 $409
2020-06-30 $425
2020-03-31 $404
2019-12-31 $405
2019-09-30 $445
2019-06-30 $429
2019-03-31 $422
2018-12-31 $212
2018-09-30 $245
2018-06-30 $286
2018-03-31 $285
2017-12-31 $306
2017-09-30 $427
2017-06-30 $449
2017-03-31 $541
2016-12-31 $569
2016-09-30 $601
2016-06-30 $719
2016-03-31 $731
2015-12-31 $752
2015-09-30 $854
2015-06-30 $878
2015-03-31 $851
2014-12-31 $800
2014-09-30 $778
2014-06-30 $2,469
2014-03-31 $2,400
2013-12-31 $2,222
2013-09-30 $1,654
2013-06-30 $1,138
2013-03-31 $855
2012-12-31 $804
2012-09-30 $605
2012-06-30 $508
2012-03-31 $597
2011-12-31 $543
2011-09-30 $410
2011-06-30 $703
2011-03-31 $663
2010-12-31 $609
2010-09-30 $618
2010-06-30 $570
2010-03-31 $744
2009-12-31 $641
2009-09-30 $587
2009-06-30 $501
2009-03-31 $610
Sector Industry Market Cap Revenue
Medical Medical Services $15.576B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00